Patent · US Active

Vaccines against Streptococcus pneumoniae serotype 5

US10596272B2 · kind B2 · utility

2Cited by

0References

21Claims

0Family size

Assignee

Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

Chakkumkal Anish · The Hague, NL
Marilda P. Lisboa · Berlin, DE
Christopher Martin · Berlin, DE
Claney Lebev Pereira · Berlin, DE
Peter H. Seeberger · Potsdam, DE
Naeem Khan · Berlin, DE

Key dates

Filing date	Jan 26, 2016
Grant date	Mar 24, 2020
Priority date	—
Expiry date	Jun 13, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6037
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to well-defined synthetic saccharides of general formula (I) that are related to the repeating unit of Streptococcus pneumoniae serotype 5 capsular polysaccharide and conjugates thereof. The conjugates and pharmaceutical compositions containing said conjugates are useful for prevention and/or treatment of diseases associated with Streptococcus pneumoniae, and more specifically against diseases associated with Streptococcus pneumoniae serotype 5. Furthermore, the synthetic saccharides of general formula (I) are useful as marker in immunological assays for detection of antibodies against Streptococcus pneumoniae bacteria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.